Translational Clinical Research in Major Eye Diseases (TCR-Eye)

导致澳大利亚大部分失明的四种眼病--老年性黄斑变性、糖尿病视网膜病变、白内障和青光眼--造成了巨大的社会经济负担，每年给我国造成10亿美元的损失。该CCRE将在墨尔本和悉尼资助一项世界领先的、基础广泛的临床和转化性研究计划，以解决这些眼病。本次CCRE开发的新知识和创新的临床策略将对临床眼科和其他医学学科的实践产生影响。

The four eye diseases that cause the majority of vision loss in Australia, age-related macular degeneration, diabetic retinopathy, cataract and glaucoma, impose a significant socio-economic burden, costing our nation -$lo billion a year. This CCRE will fund a world leading, broad-based, clinical and translational research program in Melbourne and Sydney to tackle these eye diseases. The new knowledge and innovative clinical strategies developed in this CCRE will impact on clinical ophthalmology and the practice of other medical disciplines.